Latest news
FDA Expands Approval of Pluvicto® for Metastatic Prostate Cancer: Targets a Protein Called PSMA - Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center · Thu, 06 Aug 2026 04:00:00 GMTAutonomix Medical Expands Precision Neuromodulation - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 12:15:00 GMTAutonomix patent covers mapping nerves tied to tumors and cancer pain - Stock TitanStock Titan · Tue, 04 Aug 2026 12:15:00 GMTNew therapeutic target expands options for multiple myeloma - penntoday.upenn.edupenntoday.upenn.edu · Tue, 04 Aug 2026 12:00:00 GMTExpanding Access to Targeted Therapy for Patients With Lung Cancer – The Max Foundation - OncodailyOncodaily · Sun, 02 Aug 2026 11:43:58 GMTTargeted Therapy Expands Into Adjuvant and Neoadjuvant Settings for Oncogene-Driven Early-Stage NSCLC - OncLiveOncLive · Wed, 29 Jul 2026 16:01:06 GMTZenocutuzumab Expands Targeted Treatment Options for NRG1 Fusion-Positive Cholangiocarcinoma - HMP Global Learning NetworkHMP Global Learning Network · Tue, 28 Jul 2026 15:47:28 GMT